Roger Hunter has 25 years of experience in the pharma and biotech industries where his most recent role was VP of operations with a specialty pharma firm. He holds a degree in pharmacology from the University of Aberdeen and is field-based in the US.
“It gives me great pleasure to welcome Roger Hunter as Chiltern’s new VP of strategic partnerships. Roger comes to us with a strong background in both commercial and development functions within Pharma and Biotech. He has a strong understanding of clinical development and a deep appreciation of the impact that we have on our clients,” said Stuart McGuire, VP, global business development.
